ACHIEVE Investigator Development Core

ACHIEVE 研究者开发核心

基本信息

  • 批准号:
    10494189
  • 负责人:
  • 金额:
    $ 81.69万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-24 至 2026-06-30
  • 项目状态:
    未结题

项目摘要

Abstract The overarching goal of the Investigator Development Core (IDC) is to create a climate where collaborative and innovative research can thrive, leading to improved population health through sound research and implementation science. The IDC will provide opportunities for a diverse cohort of highly skilled early-stage investigators (ESI) to develop and pilot innovative research studies by efficiently leveraging existing resources across three major research institutions in the proposed ACHIEVE GREATER. The IDC will provide training and consultation on study design and biostatistics, provide a seed funding program, and facilitate access to key infrastructure including banked biospecimens and electronic health records, and an array of data located in the newly developed Wayne State University (WSU) Google-Cloud-based data warehouse, ingestion, and dissemination platform. The core function of the IDC is to promote the research careers of the pilot project awardees to become highly competitive applicants for competitive extramural support. The IDC will specifically encourage early-stage investigators from different disciplines and backgrounds to focus on chronic disease disparities to enhance workforce diversity. The specific aims of the IDC are to plan each year's funding opportunity with input from our community advisors and ACHIEVE GREATER program leaders. This program will be available to the ACHIEVE GREATER membership and broader Wayne State University (WSU), Henry Ford Health System (HFHS) and Case Western Reserve University (CWRU)/University Hospitals (UH) research communities. Interested applicants will submit a letter of intent (LOI) which will be reviewed by the Scientific Advisory Committee ( SAC). Applicants with highly meritorious LOIs will be invited to submit a full application and will receive assistance from the administrative core on biostatistics, study design, IRB and other regulatory matters. The IDC will award six new pilot project grants each year of the 5-year ACHIEVE GREATER funding cycle with each award including funds of $40,000 over a 1-year period. In addition, we will provide awardees with programmatic support, which includes IRB as well as statistical support at no cost to them. The IDC Director (Dr. Safwan Badr – WSU) and Assistant Director (Dr. Sadeer Al-Kindi – CWRU) will oversee an advisory team that meets regularly with ACHIEVE GREATER pilot project recipients to review progress and provide guidance. Finally, we will track success measures including publications and competitive extramural awards. Overall, the IDC will nurture and support transformational research on chronic disease prevention with favorable impact on population health.
摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

M. Safwan Badr其他文献

M. Safwan Badr的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('M. Safwan Badr', 18)}}的其他基金

ACHIEVE Investigator Development Core
ACHIEVE 研究者开发核心
  • 批准号:
    10437394
  • 财政年份:
    2021
  • 资助金额:
    $ 81.69万
  • 项目类别:
ACHIEVE Investigator Development Core
ACHIEVE 研究者开发核心
  • 批准号:
    10662509
  • 财政年份:
    2021
  • 资助金额:
    $ 81.69万
  • 项目类别:
Central Sleep Apnea: Physiologic Mechanisms to Inform Treatment
中枢性睡眠呼吸暂停:指导治疗的生理机制
  • 批准号:
    10578689
  • 财政年份:
    2020
  • 资助金额:
    $ 81.69万
  • 项目类别:
Central Sleep Apnea: Physiologic Mechanisms to Inform Treatment
中枢性睡眠呼吸暂停:指导治疗的生理机制
  • 批准号:
    10390291
  • 财政年份:
    2020
  • 资助金额:
    $ 81.69万
  • 项目类别:
Central Sleep Apnea: Physiologic Mechanisms to Inform Treatment
中枢性睡眠呼吸暂停:指导治疗的生理机制
  • 批准号:
    9889338
  • 财政年份:
    2020
  • 资助金额:
    $ 81.69万
  • 项目类别:
Improving outcomes for patients with SDB and insufficient sleep
改善 SDB 和睡眠不足患者的预后
  • 批准号:
    10488651
  • 财政年份:
    2019
  • 资助金额:
    $ 81.69万
  • 项目类别:
Improving outcomes for patients with SDB and insufficient sleep
改善 SDB 和睡眠不足患者的预后
  • 批准号:
    10689812
  • 财政年份:
    2019
  • 资助金额:
    $ 81.69万
  • 项目类别:
Improving outcomes for patients with SDB and insufficient sleep
改善 SDB 和睡眠不足患者的预后
  • 批准号:
    10241257
  • 财政年份:
    2019
  • 资助金额:
    $ 81.69万
  • 项目类别:
Sleep-Disordered Breathing in patients with C-SCI: Mechanisms and Therapy
C-SCI 患者的睡眠呼吸障碍:机制和治疗
  • 批准号:
    9331700
  • 财政年份:
    2016
  • 资助金额:
    $ 81.69万
  • 项目类别:
Sleep and Breathing in Patients With Spinal Cord Injury
脊髓损伤患者的睡眠和呼吸
  • 批准号:
    8967213
  • 财政年份:
    2014
  • 资助金额:
    $ 81.69万
  • 项目类别:

相似国自然基金

水稻边界发育缺陷突变体abnormal boundary development(abd)的基因克隆与功能分析
  • 批准号:
    32070202
  • 批准年份:
    2020
  • 资助金额:
    58 万元
  • 项目类别:
    面上项目
Development of a Linear Stochastic Model for Wind Field Reconstruction from Limited Measurement Data
  • 批准号:
  • 批准年份:
    2020
  • 资助金额:
    40 万元
  • 项目类别:

相似海外基金

Development of a new solid tritium breeder blanket
新型固体氚增殖毯的研制
  • 批准号:
    2908923
  • 财政年份:
    2027
  • 资助金额:
    $ 81.69万
  • 项目类别:
    Studentship
Optimal utility-based design of oncology clinical development programmes
基于效用的肿瘤学临床开发项目的优化设计
  • 批准号:
    2734768
  • 财政年份:
    2026
  • 资助金额:
    $ 81.69万
  • 项目类别:
    Studentship
REU Site: Microbial Biofilm Development, Resistance, & Community Structure
REU 网站:微生物生物膜的发展、耐药性、
  • 批准号:
    2349311
  • 财政年份:
    2025
  • 资助金额:
    $ 81.69万
  • 项目类别:
    Continuing Grant
SoundDecisions - Musical Listening, Decision Making, And Equitable Development In The Mekong Delta
SoundDecisions - 湄公河三角洲的音乐聆听、决策和公平发展
  • 批准号:
    EP/Z000424/1
  • 财政年份:
    2025
  • 资助金额:
    $ 81.69万
  • 项目类别:
    Research Grant
Bio-MATSUPER: Development of high-performance supercapacitors based on bio-based carbon materials
Bio-MATSUPER:开发基于生物基碳材料的高性能超级电容器
  • 批准号:
    EP/Z001013/1
  • 财政年份:
    2025
  • 资助金额:
    $ 81.69万
  • 项目类别:
    Fellowship
Development of a Cell-Based Assay for Tetanus Vaccine Quality Control
破伤风疫苗质量控制细胞检测方法的开发
  • 批准号:
    10101986
  • 财政年份:
    2024
  • 资助金额:
    $ 81.69万
  • 项目类别:
    Collaborative R&D
HURR — Platform Development
HURR – 平台开发
  • 批准号:
    10103254
  • 财政年份:
    2024
  • 资助金额:
    $ 81.69万
  • 项目类别:
    Investment Accelerator
Automatic battery swapping cabinet development for scalability of e-mobility in Uganda
自动电池交换柜开发,以提高乌干达电动汽车的可扩展性
  • 批准号:
    10080435
  • 财政年份:
    2024
  • 资助金额:
    $ 81.69万
  • 项目类别:
    Collaborative R&D
Development of digital diagnostics services for Parkinson’s disease
开发帕金森病数字诊断服务
  • 批准号:
    10086932
  • 财政年份:
    2024
  • 资助金额:
    $ 81.69万
  • 项目类别:
    Collaborative R&D
RestoreDNA: Development of scalable eDNA-based solutions for biodiversity regulators and nature-related disclosure
RestoreDNA:为生物多样性监管机构和自然相关披露开发可扩展的基于 eDNA 的解决方案
  • 批准号:
    10086990
  • 财政年份:
    2024
  • 资助金额:
    $ 81.69万
  • 项目类别:
    Collaborative R&D
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了